Counter prescription of simvastatin: the views of community pharmacists

J. Howell, David Brown

Research output: Contribution to journalArticlepeer-review


Focal Points ■ Pharmacists’ reasons for not being in favour of the over-the-counter (OTC) statin were multifactorial and provide indications of how their misgivings might be addressed ■ Provision of a satisfactory and convincing evidence base might improve acceptance by the pharmaceutical community, of future prescription – only medicine (POM) to pharmacy medicine (P) switches
Original languageEnglish
Pages (from-to)B49-B50
JournalInternational Journal of Pharmacy Practice
Issue numberS2
Publication statusPublished - Sept 2006


Dive into the research topics of 'Counter prescription of simvastatin: the views of community pharmacists'. Together they form a unique fingerprint.

Cite this